Literature DB >> 2100265

Early C. elegans embryos are transcriptionally active.

I E Schauer1, W B Wood.   

Abstract

We have developed a nucleotide incorporation assay for run-on transcription in C. elegans embryonic extracts as an approach to characterizing early transcription. The incorporation is primarily polymerase II-catalyzed RNA synthesis, producing transcripts of the expected size range for mRNAs. Incorporation is insensitive to inhibitors of reinitiation, indicating that the activity represents primarily elongation of nascent chains initiated prior to extract preparation. The transcripts produced appear to be unprocessed pre-mRNAs. Hybridization of labeled transcripts from extracts of staged embryos to a set of cloned genes suggests that the specificity of the in vitro reaction accurately reflects developmentally regulated in vivo transcription. Comparative analyses of transcription in extracts from various stages indicate that pregastrulation embryos are active transcriptionally and that the level of transcription per nucleus is approximately constant throughout embryogenesis. Furthermore, most embryonically expressed genes are already being transcribed in pregastrulation embryos. We also demonstrate that the labeled embryonic run-on transcripts can be used as probes to screen for sequences transcribed preferentially in pregastrulation embryos. There appears to be only a small set of such sequences, which could represent a previously unsuspected class of embryonically transcribed genes important for early embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2100265     DOI: 10.1242/dev.110.4.1303

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  19 in total

1.  Evidence for multiple promoter elements orchestrating male-specific regulation of the her-1 gene in Caenorhabditis elegans.

Authors:  W Li; A Streit; B Robertson; W B Wood
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

2.  A genetic mosaic screen of essential zygotic genes in Caenorhabditis elegans.

Authors:  E A Bucher; I Greenwald
Journal:  Genetics       Date:  1991-06       Impact factor: 4.562

3.  Staging worms for next-generation analysis.

Authors:  L Ryan Baugh
Journal:  Nat Methods       Date:  2009-10       Impact factor: 28.547

4.  A screen for genetic loci required for hypodermal cell and glial-like cell development during Caenorhabditis elegans embryogenesis.

Authors:  P Chanal; M Labouesse
Journal:  Genetics       Date:  1997-05       Impact factor: 4.562

Review 5.  Repression of somatic cell fate in the germline.

Authors:  Valérie J Robert; Steve Garvis; Francesca Palladino
Journal:  Cell Mol Life Sci       Date:  2015-06-05       Impact factor: 9.261

6.  Onset of transcription in Patella vulgata coincides with cell cycle elongation and expression of tubulin genes.

Authors:  André E van Loon; Hans J Goedemans; Mo E M Weijtens; A J J M Daemen
Journal:  Rouxs Arch Dev Biol       Date:  1995-01

Review 7.  Early transcription in different animal species: implication for transition from maternal to zygotic control in development.

Authors:  Yannick Andéol
Journal:  Rouxs Arch Dev Biol       Date:  1994-01

8.  Genetic and molecular characterization of the caenorhabditis elegans gene, mel-26, a postmeiotic negative regulator of mei-1, a meiotic-specific spindle component.

Authors:  M R Dow; P E Mains
Journal:  Genetics       Date:  1998-09       Impact factor: 4.562

9.  Global transcriptional repression in C. elegans germline precursors by regulated sequestration of TAF-4.

Authors:  Tugba Guven-Ozkan; Yuichi Nishi; Scott M Robertson; Rueyling Lin
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

10.  Large-scale sorting of C. elegans embryos reveals the dynamics of small RNA expression.

Authors:  Marlon Stoeckius; Jonas Maaskola; Teresa Colombo; Hans-Peter Rahn; Marc R Friedländer; Na Li; Wei Chen; Fabio Piano; Nikolaus Rajewsky
Journal:  Nat Methods       Date:  2009-09-06       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.